DOD Biotech Public Company Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was THB 412.929 million compared to THB 345.142 million a year ago. Operating income was THB 45.817 million compared to THB 22.067 million a year ago. Net income was THB 55.129 million compared to THB 27.956 million a year ago. Basic earnings per share from continuing operations was THB 0.13 compared to THB 0.07 a year ago.